GAMIL MAKAR: Open Payments
NPI 1972544815 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,755 in 227 payments from 34 companies in 2025. Trend: 2023 $5,573 · 2024 $4,729 · 2025 $15,755
Speaker / faculty: $11,250Food & beverage: $4,388Education: $118
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $12,463 |
| Axsome Therapeutics, Inc. | 23 | $571 |
| AstraZeneca Pharmaceuticals LP | 20 | $404 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $312 |
| Novo Nordisk Inc | 22 | $247 |
| Corcept Therapeutics | 5 | $191 |
| GlaxoSmithKline, LLC. | 11 | $170 |
| Amgen Inc. | 10 | $167 |
| PFIZER INC. | 14 | $161 |
| Mannkind Corporation | 4 | $116 |
Products named: VRAYLAR, CREON, Sunosi, Kerendia, Ozempic, FARXIGA, QULIPTA, Korlym.
Industry payments across NJ — which companies pay providers there.
